Rapid COVID-19 Test May Miss Large Number Of Cases

The Abbott ID test, approved by the FDA for rapid COVID-19 results, was found to miss nearly half of positive cases in a preliminary NYU study. The study, not yet peer-reviewed, deemed the test's accuracy unacceptable. Abbott questioned the study's methodology, claiming a false negative rate of 0.02% and defending the test's performance. The test is widely distributed and used by the White House, which has not commented on the study.

What new insight or understanding did you gain from this video?